Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 7

2 Introduction 8

• 2.1 Cardiac Ablation Devices Overview 8

3 Products under Development 9

• 3.1 Cardiac Ablation Devices - Pipeline Products by Stage of Development 9
• 3.2 Cardiac Ablation Devices - Pipeline Products by Territory 10
• 3.3 Cardiac Ablation Devices - Pipeline Products by Regulatory Path 11
• 3.4 Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date 12
• 3.5 Cardiac Ablation Devices - Ongoing Clinical Trials 13

4 Cardiac Ablation Devices - Pipeline Products under Development by Companies 14

• 4.1 Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development 14
• 4.2 Cardiac Ablation Devices - Pipeline Products by Stage of Development 15

5 Cardiac Ablation Devices Companies and Product Overview 16

• 5.1 AblaCor Medical Corporation Company Overview 16
  • 5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 16
• 5.2 Adagio Medical Inc. Company Overview 18
  • 5.2.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
• 5.3 AFreeze GmbH Company Overview 21
  • 5.3.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.4 AngioDynamics Inc Company Overview 25
  • 5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.5 Atrian Medical Ltd Company Overview 26
  • 5.5.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
• 5.6 AtriCure Inc Company Overview 27
  • 5.6.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 27
• 5.7 Baylis Medical Company Inc Company Overview 32
  • 5.7.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.8 Corfigo Inc Company Overview 33
  • 5.8.1 Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview 33
• 5.9 Coridea, LLC Company Overview 34
  • 5.9.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
• 5.10 CPSI Biotech Company Overview 35
  • 5.10.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 35
• 5.11 Helical Solutions, Inc. (Inactive) Company Overview 39
  • 5.11.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.12 Johns Hopkins University Company Overview 40
  • 5.12.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.13 Kardium Inc Company Overview 42
  • 5.13.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.14 LuxCath, LLC Company Overview 43
  • 5.14.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.15 Medtronic plc Company Overview 44
  • 5.15.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.16 Northwestern University Company Overview 49
  • 5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 49
• 5.17 Sheba Medical Center Company Overview 50
  • 5.17.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 50
• 5.18 Spectranetics Corp Company Overview 51
  • 5.18.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 51
• 5.19 Thermedical Inc Company Overview 52
  • 5.19.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 52
• 5.20 Tufts Medical Center Company Overview 55
  • 5.20.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 55
• 5.21 University of California Los Angeles Company Overview 56
  • 5.21.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 56
• 5.22 University of Chicago Company Overview 57
  • 5.22.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 57
• 5.23 VytronUS Inc Company Overview 58
  • 5.23.1 VytronUS Inc Pipeline Products & Ongoing Clinical Trials Overview 58

6 Cardiac Ablation Devices- Recent Developments 62

• 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 62
• 6.2 Nov 18, 2019: Biosense Webster launches a two-pronged initiative to tackle the new millennium epidemic of Atrial Fibrillation 64
• 6.3 Nov 14, 2019: Stereotaxis reports 2019 third quarter financial results 65
• 6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 66
• 6.5 Nov 08, 2019: Stereotaxis and Catheter Precision combine robotic navigation and preoperative arrhythmia localization to treat cardiac arrhythmias 67

7 Appendix 112

• 7.1 Methodology 112
• 7.2 About GlobalData 115
• 7.3 Contact Us 115

Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Cardiac Ablation Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiac Ablation Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Ablation Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiac Ablation Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiac Ablation Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiac Ablation Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date